Granules India secures ANDA approval for Pantoprazole Sodium Tablets from FDA
Granules India Limited, a prominent player in the pharmaceutical industry, has announced that the US Food & Drug Administration (US FDA) has approved its Abbreviated New Drug Application (ANDA) for Pantoprazole Sodium Delayed-Release Tablets USP, 20 mg and 40 mg. This approval is a significant milestone for the company, marking its 64th ANDA approval from […]